查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092156

醫療設備檢測市場－2026-2032年全球市場預測

Medical Device Testing Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫療設備測試市場將成長至 227.5 億美元，複合年成長率為 8.75%。

主要市場統計數據
基準年 2025 126.4億美元
預計年份：2026年 136.9億美元
預測年份 2032 227.5億美元
複合年成長率 (%) 8.75%

醫療設備測試執行摘要

醫療設備測試是安全、有效且受監管的醫療技術的基礎，涵蓋電氣安全、生物相容性、無菌保證、軟體驗證、可用性工程、網路安全、效能檢驗、包裝完整性和上市後監測。隨著醫療設備日益網路化、軟體主導、小型化以及直接面向患者，測試項目不僅要證明產品符合技術規範，還要證明其在真實臨床環境和不斷變化的監管要求下保持安全。全球監管框架，例如美國FDA品質系統法規和品質管理系統法規的過渡、歐盟醫療設備法規、ISO 13485法規結構管理、ISO 14971風險管理、IEC 60601電氣安全、IEC 62304醫療軟體生命週期流程、ISO 10993生物學製造企業評估以及ISO 11607障礙包裝商，持續影響控制屏障從新開發週期到影響的證據包裝。經營團隊重點顯而易見。嚴格的醫療設備測試可以減少監管摩擦，提高病人安全，增強產品可靠性，並改善對審計、申報、設計變更和上市後義務的準備工作。

醫療設備測試領域的變革性變化

醫療設備測試環境正從後期合規性檢驗轉向基於生命週期的整合式保障。監管機構日益要求製造商將風險管理、人因工程、臨床評估、網路安全和軟體保障整合到設計控制中，而不是將測試視為最終查核點。連網型設備、穿戴式監測器、數位療法、機器人系統、植入式技術和照護現場診斷的普及，正在將測試範圍擴展到傳統的機械和電氣評估之外。網路安全已成為一項核心要求，監管機構強調威脅建模、安全設計、軟體材料清單(SBOM)、漏洞監控和協調揭露。同時，全球協調仍未完成，製造商必須應對區域性的證據要件、文件格式、語言要求、臨床資料標準和合格評定路徑。實驗室和製造商也在採用自動化、數位測試記錄、模擬和基於模型的工程技術來提高可追溯性和可重複性。這些變化使那些在產品開發週期早期就協調監管策略、品質系統、工程檢驗和臨床證據計劃的組織獲得了優勢。

人工智慧對醫療設備測試的累積影響

人工智慧 (AI) 正在改變醫療設備的測試方式，它既增加了待測產品的複雜性，也提高了檢驗方法的精細化程度。 AI 驅動的醫療設備需要提供證據，證明其演算法在目標患者群體、臨床工作流程、資料品質要求以及可預見的誤用場景下能夠安全運作。測試必須涵蓋資料集的代表性、偏差評估、模型穩健性、可解釋性（如適用）、網路安全風險、人工監督以及針對自適應或持續改進系統的變更管理。監管機構越來越重視預先規劃的變更管理、透明度、實際效能監控以及 AI 和機器學習驅動的醫療軟體的生命週期管治。 AI 還透過輔助自動缺陷檢測、識別生產資料中的異常、加快文件審核速度、預測性維護測試設備以及跨檢驗和驗證資料集進行統計模式識別來改善測試操作。然而，AI 帶來的效率提升並不能取代監管課責。製造商必須維護檢驗的工具、受控的資料管道、可審計的文件以及明確的人工決策權。這些因素結合起來，形成了一個資料密集的測試環境，演算法效能、軟體安全性、臨床有效性和上市後學習必須作為一個整體來證明。

醫療設備測試的關鍵區域見解

隨著中國、日本、印度、韓國、澳洲和東南亞國協法律規範的加強、對本地臨床證據的要求不斷提高以及國內生產能力的增強，亞太地區在醫療設備測試領域的重要性日益凸顯。中國的醫療設備註冊要求、印度不斷完善的醫療設備法規、日本成熟的品質和臨床審查體係以及澳洲的治療產品框架，都推動了對嚴格的文件、生物相容性、電氣安全性和軟體驗證的需求。以美國和加拿大為首的北美地區仍然是醫療設備測試要求最為嚴格的地區之一，對品質系統合規性、上市前證據、上市後報告、人因檢驗、網路安全和實際應用性能的期望顯著影響著全球測試策略。拉丁美洲的法規環境複雜多樣，其中巴西和墨西哥是註冊、品質文件、標籤和合格評定途徑的關鍵參考市場。在該地區，成功的測試策略必須考慮各國的具體申請要求和語言本地化。在歐洲，歐盟醫療設備法規和體外診斷醫療設備法規正在推動重大的結構性變革，日益重視臨床評估、上市後臨床追蹤、技術文件、認證審查和持續安全監測。在中東，醫療技術監管正透過國家衛生機構和採購主導的品質要求不斷推進，尤其是在海灣合作理事會（GCC）國家，進口醫療設備必須提供國際認可的安全性和性能證據。非洲的情況雖然仍不盡相同，但越來越依賴加強監管、公共衛生採購標準以及與國際標準的接軌。對於用於診斷、孕產婦保健、感染疾病控制和提供基本醫療保健服務的醫療設備而言，檢測準備的重要性日益凸顯。

全球醫療設備測試市場關鍵群體分析

在東協，透過區域醫療設備框架加強監管一致性，同時維持國家報名手續，其戰略重要性日益凸顯。這就要求技術文件具有高度的適應性，並提供一致的產品測試證據。海灣合作理事會（GCC）的特點是高度依賴進口醫療技術，集中採購的影響顯著，且各國監管機構通常參考國際標準，因此品質認證、標籤準確性和安全文件對於市場准入至關重要。歐盟（EU）仍然是嚴格合格評定的標桿，其醫療器材法規（MDR）和體外診斷醫療器材法規（IVDR）的要求提高了對所有醫療設備類別的臨床評估、上市後監測、風險管理和技術文件的期望。金磚國家整體呈現多樣化的測試和合規環境，中國、印度、巴西、俄羅斯和南非的監管程序和當地經銷商要求各不相同，並且越來越重視與國家標準的一致性。七國集團（G7）憑藉其先進的監管體系、成熟的品質基礎設施、參與既定的標準化活動以及健全的上市後監測體系，對全球醫療設備測試標準產生影響，並常常塑造著對軟體、網路安全和臨床證據的期望。北約成員國在需要高可靠性、網路安全韌性、供應鏈保障以及遵守公認的安全和性能標準以在惡劣的醫療和野外環境中部署的領域發揮著至關重要的作用，包括國防醫療系統、應急準備和可互操作的醫療技術。

關鍵國家在醫療設備測試合規性方面的見解

美國繼續透過基於風險的分類、上市前審查流程、廣泛接受的共識標準、品質系統檢查、人為因素指南、網路安全要求以及上市後報告義務，對醫療設備測試提出具有影響力的期望。在加拿大，重點在於許可、品管認證、安全性和有效性證據、雙語標籤要求以及上市後監測。墨西哥的監管流程要求仔細關注分類、文件、認可機構、標籤和等效性考慮。同時，巴西擁有拉丁美洲最完善的監管體系之一，對註冊、良好生產規範 (GMP) 證據和本地合規管理有著嚴格的要求。在歐洲，英國脫歐後擁有自己的醫療設備監管流程，而德國、法國、義大利和西班牙仍透過認證機構、臨床評估審查、監測系統以及國家主管機關的監督，在歐盟醫療器材法規 (EU MDR) 的實施中發揮核心作用。俄羅斯維持自己的註冊和測試要求，包括要求提供特定文件和符合性證據的本地監管程序。中國正透過系統化的註冊要求、對許多產品實施現場檢測要求以及更加重視臨床評估和品管，加強對醫療設備的監管。印度正在擴大其監管範圍，涵蓋更廣泛的醫療設備，並日益重視分類、許可、品質系統和性能文件。日本採用成熟的法規結構，強調品管、臨床證據以及每種醫療設備的批准或認證途徑。澳洲的框架要求在國家治療藥物註冊中心註冊，並提供合格評定和上市後合規性的證據。韓國擁有完善的監管體系，對醫療設備（尤其是在數位醫療、診斷和先進治療技術領域）的安全性、軟體、臨床性能和品管進行嚴格審查。

為醫療設備測試負責人提供的實用建議。

行業領導者應從概念和設計階段就整合測試策略，而不是等到原型完成或提交準備就緒才開始。一個有效的方案始於標準映射、醫療設備分類分析、預期用途定義、風險管理規劃以及儘早識別整個司法管轄區所需的證據。製造商必須在其法規遵循、品質保證、工程、臨床、網路安全和上市後監測團隊之間建立跨職能管治，以確保檢驗、臨床評估、可用性和監測數據能夠追溯到風險和要求。對於軟體和人工智慧驅動的設備，領導者應實施受控開發環境、經驗證的工具、資料集管治、偏差測試、網路安全威脅建模和生命週期監控計劃。對於互聯和植入式醫療設備，測試應優先考慮互通性、電磁相容性、電池安全性、材料特性、滅菌、包裝完整性和長期可靠性。在國際上運作的組織需要維護模組化的技術文檔，使其能夠適應美國、歐盟、亞太地區、拉丁美洲、中東和非洲的監管要求，同時保持一致性。投資於數位化品管、自動化測試可追溯性、供應商合格和隨時可審核的記錄，可以減輕糾正措施的負擔，並提高接受檢查的準備程度。

醫療設備測試與分析的調查方法

本執行摘要的調查方法是基於對公開的法規結構、國際共識標準、衛生監管機構指南、品管要求、合格評定原則以及與醫療設備測試相關的已記錄的行業合規實踐的系統性審查和整合。資訊來源包括經認可的監管機構、標準化機構、國家醫療設備法規、軟體和網路安全指南、臨床評估要求、上市後監管義務以及對已建立品質系統的預期。本分析優先考慮基於檢驗的法規和標準的見解，而非商業性估算、市場規模估算、佔有率分析或預測。透過比較各司法管轄區的監管成熟度、合格評定要求、文件要求、品質系統義務和上市後控制，得出區域、群體和國家層面的具體觀點。該調查方法強調其對製造商、實驗室、監管回應團隊和品管經理的實際意義，旨在幫助他們將證據生成與患者安全、產品性能和全球合規義務相結合。

結論：醫療設備測試是策略合規的強制性要求

醫療設備測試已成為一項策略性職能，直接影響監管核准的準備、病人安全、產品可靠性和全球商業化。隨著醫療設備不斷整合先進材料、無線連接、內建軟體、人工智慧演算法、遠端監控功能和複雜的臨床工作流程，這一領域也不斷擴展。監管機構日益關注生命週期證據、網路安全韌性、易用性、臨床性能、真實世界監測和透明的風險管理。將測試定位為品質和監管一體化策略的機構可以減少合規差距，提高申報質量，並增強醫療設備的長期性能。最具韌性的製造商將是那些建立全球適用的測試程序、維護可審計的技術文件、負責任地檢驗數位和人工智慧系統，並將上市後洞察持續融入設計和風險管理的製造商。在日益複雜的醫療技術領域，嚴格的醫療設備測試不僅僅是一項監管要求，更是信任、安全和永續創新的核心驅動力。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章醫療設備檢測市場：依服務類型分類

  • 測試服務
    • 生物相容性測試
      • 細胞毒性試驗
      • 致敏試驗
      • 刺激試驗
      • 系統毒性試驗
      • 基因毒性測試
    • 化學測試
      • 萃取物和洗脫液
      • 材料性能評價
      • 毒性風險評估
    • 微生物學和無菌性檢測
      • 微生物附著量測試
      • 無菌測試
      • 內毒素試驗
      • 環境監測
    • 電氣安全測試
    • 包裝驗證測試
  • 檢查服務
  • 身份驗證服務

第8章：醫療設備檢測市場：依產品類型

  • 診斷設備
    • 體外診斷醫療設備
      • 試劑和試劑盒
      • 儀器和分析設備
      • 即時檢測設備
      • 免疫檢測系統
    • 醫療影像設備
      • X光系統
      • 磁振造影（MRI）
      • 電腦斷層掃描（CT）系統
      • 超音波診斷設備
    • 診斷監測設備
      • 血糖監測設備
      • 心臟監測設備
      • 神經監測設備
  • 治療設備
    • 外科器械
    • 植入式醫療設備
      • 心血管植入
      • 整形外科植入
      • 植入
    • 透析機
  • 病患監測設備
  • 藥物輸送裝置
    • 注射裝置
    • 點滴幫浦
    • 吸入裝置

第9章：醫療設備測試市場：依階段分類

  • 臨床前階段
    • 體外試驗
    • 體外試驗
    • 體內動物試驗
  • 臨床階段
  • 上市後階段

第10章：醫療設備偵測市場：依採購方式分類

  • 公司內部測試
  • 外包測試

第11章醫療設備偵測市場：依器材類別分類

  • I類醫療設備
  • Ⅱ類醫療設備
  • III類醫療設備

第12章：醫療設備測試市場：依最終用戶分類

  • 醫療設備製造商
  • 受託研究機構
  • 醫院和診所
  • 學術和研究機構

第13章：醫療設備偵測市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：醫療設備檢測市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：醫療設備檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Applus+Laboratories
  • BSI Group The Netherlands BV
  • Bureau Veritas SA
  • Charles River Laboratories International, Inc.
  • CSA Group Testing & Certification Inc.
  • DEKRA SE
  • DQS Medizinprodukte GmbH
  • Element Materials Technology Group Limited
  • EMTEK, LLC
  • Eurofins Scientific SE
  • IMQ SpA
  • Intertek Group plc
  • LRQA Group Limited
  • Medistri SA
  • NAMSA
  • Nelson Laboratories, LLC
  • Pace Analytical Services, LLC
  • Qserve Group BV
  • SGS SA
  • Toxikon Corporation
  • TUV SUD AG
  • UL Solutions Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-6611A5111648

The Medical Device Testing Market is projected to grow by USD 22.75 billion at a CAGR of 8.75% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.64 billion
Estimated Year [2026] USD 13.69 billion
Forecast Year [2032] USD 22.75 billion
CAGR (%) 8.75%

Medical Device Testing Executive Summary

Medical device testing is the evidence engine behind safe, effective, and compliant healthcare technologies, spanning electrical safety, biocompatibility, sterility assurance, software validation, usability engineering, cybersecurity, performance verification, packaging integrity, and post-market surveillance. As medical devices become more connected, software-defined, miniaturized, and patient-facing, testing programs must prove not only that products meet technical specifications but also that they remain safe across real-world clinical environments and evolving regulatory expectations. Global regulatory frameworks such as the U.S. FDA Quality System Regulation and Quality Management System Regulation transition, the EU Medical Device Regulation, ISO 13485 quality management, ISO 14971 risk management, IEC 60601 electrical safety, IEC 62304 medical software lifecycle processes, ISO 10993 biological evaluation, and ISO 11607 sterile barrier packaging requirements continue to shape how manufacturers design evidence strategies from early development through product lifecycle management. The executive priority is clear: robust medical device testing reduces regulatory friction, strengthens patient safety, supports product reliability, and improves readiness for audits, submissions, design changes, and post-market obligations.

Transformative Shifts in the Medical Device Testing Landscape

The medical device testing landscape is shifting from late-stage compliance validation toward integrated, lifecycle-based assurance. Regulators increasingly expect manufacturers to embed risk management, human factors, clinical evaluation, cybersecurity, and software assurance into design controls rather than treating testing as a final checkpoint. The growth of connected devices, wearable monitors, digital therapeutics, robotic systems, implantable technologies, and point-of-care diagnostics has broadened the scope of testing beyond traditional mechanical and electrical assessments. Cybersecurity has become a core requirement, with regulators emphasizing threat modeling, secure design, software bill of materials, vulnerability monitoring, and coordinated disclosure. At the same time, global harmonization remains incomplete, requiring manufacturers to manage region-specific evidence expectations, documentation formats, language requirements, clinical data standards, and conformity assessment routes. Laboratories and manufacturers are also adopting automation, digital test records, simulation, and model-based engineering to improve traceability and repeatability. These shifts reward organizations that align regulatory strategy, quality systems, engineering validation, and clinical evidence planning early in the product development cycle.

Cumulative Impact of Artificial Intelligence on Medical Device Testing

Artificial intelligence is reshaping medical device testing by expanding both the complexity of products under review and the sophistication of validation methods. AI-enabled medical devices require evidence that algorithms perform safely across intended populations, clinical workflows, data quality conditions, and foreseeable misuse scenarios. Testing must address dataset representativeness, bias assessment, model robustness, explainability where appropriate, cybersecurity exposure, human oversight, and change management for adaptive or continuously improved systems. Regulatory authorities have increased focus on predetermined change control plans, transparency, real-world performance monitoring, and lifecycle governance for AI and machine learning-enabled medical software. AI is also improving testing operations by supporting automated defect detection, anomaly identification in production data, accelerated document review, predictive maintenance for test equipment, and statistical pattern recognition across verification and validation datasets. However, AI-driven efficiency does not replace regulatory accountability; manufacturers must maintain validated tools, controlled data pipelines, audit-ready documentation, and clear human decision authority. The cumulative impact is a more data-intensive testing environment where algorithmic performance, software safety, clinical relevance, and post-market learning must be demonstrated together.

Key Regional Insights for Medical Device Testing

Asia-Pacific is becoming increasingly important for medical device testing as China, Japan, India, South Korea, Australia, and ASEAN economies strengthen regulatory oversight, local clinical evidence expectations, and domestic manufacturing capabilities. China's device registration requirements, India's expanding device rules, Japan's established quality and clinical review systems, and Australia's therapeutic goods framework are driving demand for disciplined documentation, biocompatibility, electrical safety, and software validation. North America remains one of the most rigorous regions for medical device testing, led by the United States and Canada, where quality system compliance, premarket evidence, post-market reporting, human factors validation, cybersecurity, and real-world performance expectations strongly influence global testing strategies. Latin America presents a diverse regulatory environment, with Brazil and Mexico serving as key reference markets for registration, quality documentation, labeling, and conformity pathways; successful testing strategies in the region must account for country-specific submission requirements and language localization. Europe has undergone major structural change under the EU Medical Device Regulation and In Vitro Diagnostic Regulation, increasing emphasis on clinical evaluation, post-market clinical follow-up, technical documentation, notified body scrutiny, and ongoing safety surveillance. The Middle East is advancing medical technology regulation through national health authorities and procurement-driven quality requirements, particularly in GCC countries where imported devices must demonstrate internationally recognized safety and performance evidence. Africa remains heterogeneous, with growing reliance on regulatory strengthening initiatives, public health procurement standards, and alignment with international norms; testing readiness is increasingly relevant for devices used in diagnostics, maternal care, infectious disease management, and essential healthcare delivery.

Key Group Insights Across Global Medical Device Testing Markets

ASEAN is gaining strategic relevance as member states work toward greater regulatory convergence through regional medical device frameworks while still maintaining national registration procedures, creating a need for adaptable technical files and consistent product testing evidence. The GCC is characterized by high dependence on imported medical technologies, centralized procurement influences, and national regulatory authorities that commonly reference international standards, making quality certification, labeling accuracy, and safety documentation critical for market access. The European Union remains a benchmark for stringent conformity assessment, with MDR and IVDR requirements elevating expectations for clinical evaluation, post-market surveillance, risk management, and technical documentation across device classes. BRICS countries collectively represent a diverse testing and compliance environment, with China, India, Brazil, Russia, and South Africa each maintaining distinct regulatory procedures, local representation requirements, and increasing attention to domestic standards alignment. G7 countries influence global medical device testing norms through advanced regulatory systems, mature quality infrastructure, established standards participation, and strong post-market vigilance practices, often shaping expectations for software, cybersecurity, and clinical evidence. NATO countries are relevant where defense health systems, emergency preparedness, and interoperable medical technologies require high reliability, cybersecurity resilience, supply chain assurance, and compliance with recognized safety and performance standards for deployment in demanding healthcare and field environments.

Key Country Insights for Medical Device Testing Compliance

The United States continues to set influential expectations for medical device testing through risk-based classification, premarket review pathways, recognized consensus standards, quality system inspections, human factors guidance, cybersecurity expectations, and post-market reporting obligations. Canada emphasizes licensing, quality management certification, safety and effectiveness evidence, bilingual labeling considerations, and post-market vigilance. Mexico's regulatory pathway requires careful attention to classification, documentation, authorized representation, labeling, and equivalence considerations, while Brazil applies one of Latin America's most developed regulatory systems with strong requirements for registration, good manufacturing practice evidence, and local compliance controls. In Europe, the United Kingdom operates its own medical device regulatory pathway following its departure from the EU, while Germany, France, Italy, and Spain remain central to EU MDR implementation through notified body capacity, clinical evaluation scrutiny, vigilance systems, and national competent authority oversight. Russia maintains distinct registration and testing requirements, including local regulatory procedures that require specific documentation and conformity evidence. China has intensified device oversight through structured registration requirements, local testing expectations for many products, and greater attention to clinical evaluation and quality management. India is expanding regulation across a broader range of medical devices, increasing the importance of classification, licensing, quality systems, and performance documentation. Japan applies a mature regulatory framework with strong emphasis on quality management, clinical evidence, and device-specific approval or certification routes. Australia's framework requires inclusion in the national therapeutic goods register supported by conformity assessment evidence and post-market compliance. South Korea has a well-developed regulatory system with rigorous review of device safety, software, clinical performance, and quality management, particularly for digital health, diagnostics, and advanced therapeutic technologies.

Actionable Recommendations for Medical Device Testing Leaders

Industry leaders should integrate testing strategy at the concept and design-input stage rather than waiting for prototype completion or submission preparation. A defensible approach begins with standards mapping, device classification analysis, intended-use definition, risk management planning, and early identification of required evidence across target jurisdictions. Manufacturers should build cross-functional governance between regulatory affairs, quality assurance, engineering, clinical, cybersecurity, and post-market teams to ensure that verification, validation, clinical evaluation, usability, and surveillance data remain traceable to risks and requirements. For software and AI-enabled devices, leaders should implement controlled development environments, validated tools, dataset governance, bias testing, cybersecurity threat modeling, and lifecycle monitoring plans. For connected and implantable devices, testing should prioritize interoperability, electromagnetic compatibility, battery safety, materials characterization, sterilization, packaging integrity, and long-term reliability. Organizations expanding internationally should maintain modular technical documentation that can be adapted for U.S., EU, Asia-Pacific, Latin American, Middle Eastern, and African regulatory expectations without compromising consistency. Investment in digital quality management, automated test traceability, supplier qualification, and audit-ready records can reduce remediation burden and strengthen inspection preparedness.

Research Methodology for Medical Device Testing Analysis

The research methodology for this executive summary is based on structured review and synthesis of publicly available regulatory frameworks, international consensus standards, health authority guidance, quality management requirements, conformity assessment principles, and documented industry compliance practices relevant to medical device testing. Sources considered include recognized regulatory authorities, standards organizations, national medical device rules, guidance on software and cybersecurity, clinical evaluation requirements, post-market surveillance obligations, and established quality system expectations. The analysis prioritizes verified regulatory and standards-based insights rather than commercial estimates, market sizing, share analysis, or forecasts. Regional, group, and country perspectives were developed by comparing regulatory maturity, conformity assessment requirements, documentation expectations, quality system obligations, and post-market controls across jurisdictions. The methodology emphasizes practical relevance for manufacturers, testing laboratories, regulatory teams, and quality leaders seeking to align evidence generation with patient safety, product performance, and global compliance obligations.

Conclusion: Medical Device Testing as a Strategic Compliance Imperative

Medical device testing has become a strategic function that directly affects regulatory approval readiness, patient safety, product reliability, and global commercialization. The discipline is expanding as devices incorporate advanced materials, wireless connectivity, embedded software, AI algorithms, remote monitoring capabilities, and complex clinical workflows. Regulatory authorities are placing greater emphasis on lifecycle evidence, cybersecurity resilience, usability, clinical performance, real-world monitoring, and transparent risk management. Organizations that treat testing as an integrated quality and regulatory strategy can reduce compliance gaps, improve submission quality, and strengthen long-term device performance. The most resilient manufacturers will be those that build globally adaptable testing programs, maintain audit-ready technical documentation, validate digital and AI systems responsibly, and continuously connect post-market intelligence back into design and risk management. In a more complex healthcare technology environment, rigorous medical device testing is not only a regulatory requirement; it is a core driver of trust, safety, and sustainable innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Medical Device Testing Market, by Service Type

  • 7.1. Introduction
  • 7.2. Testing Services
    • 7.2.1. Biocompatibility Testing
      • 7.2.1.1. Cytotoxicity Testing
      • 7.2.1.2. Sensitization Testing
      • 7.2.1.3. Irritation Testing
      • 7.2.1.4. Systemic Toxicity Testing
      • 7.2.1.5. Genotoxicity Testing
    • 7.2.2. Chemistry Testing
      • 7.2.2.1. Extractables & Leachables
      • 7.2.2.2. Material Characterization
      • 7.2.2.3. Toxicological Risk Assessment
    • 7.2.3. Microbiology & Sterility Testing
      • 7.2.3.1. Bioburden Testing
      • 7.2.3.2. Sterility Testing
      • 7.2.3.3. Endotoxin Testing
      • 7.2.3.4. Environmental Monitoring
    • 7.2.4. Electrical Safety Testing
    • 7.2.5. Package Validation Testing
  • 7.3. Inspection Services
  • 7.4. Certification Services

8. Medical Device Testing Market, by Product Category

  • 8.1. Introduction
  • 8.2. Diagnostic Devices
    • 8.2.1. In-vitro Diagnostic Devices
      • 8.2.1.1. Reagents & Kits
      • 8.2.1.2. Instruments & Analyzers
      • 8.2.1.3. Point-of-Care Testing Devices
      • 8.2.1.4. Immunoassay Systems
    • 8.2.2. Imaging Devices
      • 8.2.2.1. X-ray Systems
      • 8.2.2.2. Magnetic Resonance Imaging Systems
      • 8.2.2.3. Computed Tomography Systems
      • 8.2.2.4. Ultrasound Systems
    • 8.2.3. Diagnostic Monitoring Devices
      • 8.2.3.1. Glucose Monitoring Devices
      • 8.2.3.2. Cardiac Monitoring Devices
      • 8.2.3.3. Neurological Monitoring Devices
  • 8.3. Therapeutic Devices
    • 8.3.1. Surgical Devices
    • 8.3.2. Implantable Devices
      • 8.3.2.1. Cardiovascular Implants
      • 8.3.2.2. Orthopedic Implants
      • 8.3.2.3. Dental Implants
    • 8.3.3. Dialysis Devices
  • 8.4. Patient Monitoring Devices
  • 8.5. Drug Delivery Devices
    • 8.5.1. Injection Devices
    • 8.5.2. Infusion Pumps
    • 8.5.3. Inhalation Devices

9. Medical Device Testing Market, by Phase

  • 9.1. Introduction
  • 9.2. Preclinical Phase
    • 9.2.1. In-vitro Testing
    • 9.2.2. Ex-vivo Testing
    • 9.2.3. In-vivo Animal Testing
  • 9.3. Clinical Phase
  • 9.4. Post-Market Phase

10. Medical Device Testing Market, by Sourcing Type

  • 10.1. Introduction
  • 10.2. In-House Testing
  • 10.3. Outsourced Testing

11. Medical Device Testing Market, by Device Class

  • 11.1. Introduction
  • 11.2. Class I Devices
  • 11.3. Class II Devices
  • 11.4. Class III Devices

12. Medical Device Testing Market, by End User

  • 12.1. Introduction
  • 12.2. Medical Device Manufacturers
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals & Clinics
  • 12.5. Academic & Research Institutions

13. Medical Device Testing Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Medical Device Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Device Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Applus+ Laboratories
  • 17.2. BSI Group The Netherlands B.V.
  • 17.3. Bureau Veritas SA
  • 17.4. Charles River Laboratories International, Inc.
  • 17.5. CSA Group Testing & Certification Inc.
  • 17.6. DEKRA SE
  • 17.7. DQS Medizinprodukte GmbH
  • 17.8. Element Materials Technology Group Limited
  • 17.9. EMTEK, LLC
  • 17.10. Eurofins Scientific SE
  • 17.11. IMQ S.p.A.
  • 17.12. Intertek Group plc
  • 17.13. LRQA Group Limited
  • 17.14. Medistri SA
  • 17.15. NAMSA
  • 17.16. Nelson Laboratories, LLC
  • 17.17. Pace Analytical Services, LLC
  • 17.18. Qserve Group B.V.
  • 17.19. SGS SA
  • 17.20. Toxikon Corporation
  • 17.21. TUV SUD AG
  • 17.22. UL Solutions Inc.
  • 17.23. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL MEDICAL DEVICE TESTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL MEDICAL DEVICE TESTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL MEDICAL DEVICE TESTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL MEDICAL DEVICE TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL MEDICAL DEVICE TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOCOMPATIBILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CYTOTOXICITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CYTOTOXICITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CYTOTOXICITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SENSITIZATION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SENSITIZATION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SENSITIZATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IRRITATION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IRRITATION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IRRITATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SYSTEMIC TOXICITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SYSTEMIC TOXICITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SYSTEMIC TOXICITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GENOTOXICITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GENOTOXICITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GENOTOXICITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CHEMISTRY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CHEMISTRY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHEMISTRY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACTABLES & LEACHABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACTABLES & LEACHABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACTABLES & LEACHABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MATERIAL CHARACTERIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MATERIAL CHARACTERIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MATERIAL CHARACTERIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TOXICOLOGICAL RISK ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TOXICOLOGICAL RISK ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TOXICOLOGICAL RISK ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROBIOLOGY & STERILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MICROBIOLOGY & STERILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROBIOLOGY & STERILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOBURDEN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STERILITY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STERILITY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STERILITY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOTOXIN TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENVIRONMENTAL MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENVIRONMENTAL MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENVIRONMENTAL MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ELECTRICAL SAFETY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ELECTRICAL SAFETY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ELECTRICAL SAFETY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PACKAGE VALIDATION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PACKAGE VALIDATION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PACKAGE VALIDATION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INSPECTION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INSPECTION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INSPECTION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CERTIFICATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CERTIFICATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CERTIFICATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IN-VITRO DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IN-VITRO DIAGNOSTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INSTRUMENTS & ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POINT-OF-CARE TESTING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POINT-OF-CARE TESTING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POINT-OF-CARE TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IMMUNOASSAY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IMMUNOASSAY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IMMUNOASSAY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL X-RAY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL X-RAY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL X-RAY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL COMPUTED TOMOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL COMPUTED TOMOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL COMPUTED TOMOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ULTRASOUND SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ULTRASOUND SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ULTRASOUND SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEUROLOGICAL MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NEUROLOGICAL MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEUROLOGICAL MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL THERAPEUTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IMPLANTABLE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL DIALYSIS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIALYSIS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DIALYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL INJECTION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL INJECTION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL INJECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL INFUSION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL INFUSION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL INFUSION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL INHALATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL INHALATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL INHALATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PRECLINICAL PHASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PRECLINICAL PHASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PRECLINICAL PHASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL IN-VITRO TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL IN-VITRO TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL IN-VITRO TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL EX-VIVO TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL EX-VIVO TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL EX-VIVO TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL IN-VIVO ANIMAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL IN-VIVO ANIMAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL IN-VIVO ANIMAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CLINICAL PHASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL CLINICAL PHASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL CLINICAL PHASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL POST-MARKET PHASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL POST-MARKET PHASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL POST-MARKET PHASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL IN-HOUSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL IN-HOUSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL IN-HOUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL OUTSOURCED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL OUTSOURCED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL OUTSOURCED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL CLASS I DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL CLASS I DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL CLASS I DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL CLASS II DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL CLASS II DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL CLASS II DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL CLASS III DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL CLASS III DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL CLASS III DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL DEVICE MANUFACTURERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL ACADEMIC & RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 222. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 228. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 230. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 248. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 250. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 252. LATIN AMERICA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 278. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 292. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 294. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 295. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 296. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 297. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 298. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 299. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 300. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 304. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 307. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. GLOBAL MEDICAL DEVICE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 314. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 315. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 316. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 317. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 318. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 319. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 320. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 321. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 322. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 323. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 324. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 325. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 326. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 327. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 329. ASEAN MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 331. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY TESTING SERVICES, 2018-2032 (USD MILLION)
  • TABLE 333. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY BIOCOMPATIBILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 334. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY CHEMISTRY TESTING, 2018-2032 (USD MILLION)
  • TABLE 335. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY MICROBIOLOGY & STERILITY TESTING, 2018-2032 (USD MILLION)
  • TABLE 336. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 337. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 338. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY IN-VITRO DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 339. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 340. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY DIAGNOSTIC MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 341. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 342. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY IMPLANTABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 343. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY DRUG DELIVERY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 344. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY PHASE, 2018-2032 (USD MILLION)
  • TABLE 345. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY PRECLINICAL PHASE, 2018-2032 (USD MILLION)
  • TABLE 346. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY SOURCING TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY DEVICE CLASS, 2018-2032 (USD MILLION)
  • TABLE 348. GCC MEDICAL DEVICE TESTING MARKET SIZE, BY END USER, 2018-203